JASPER THERAPEUTICS INC's ticker is and the CUSIP is 471871103. A total of 28 filers reported holding JASPER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.07 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,718,594 | -38.8% | 5,628,558 | 0.0% | 0.89% | -41.6% |
| Q3 2022 | $4,441,000 | -58.3% | 5,628,558 | 0.0% | 1.52% | -55.4% |
| Q2 2022 | $10,638,000 | -45.5% | 5,628,558 | 0.0% | 3.40% | -38.5% |
| Q1 2022 | $19,531,000 | -55.7% | 5,628,558 | 0.0% | 5.54% | -48.2% |
| Q4 2021 | $44,128,000 | -24.0% | 5,628,558 | 0.0% | 10.69% | -18.8% |
| Q3 2021 | $58,030,000 | – | 5,628,558 | – | 13.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 8,519,648 | $5,963,754 | 7.92% |
| Velan Capital Investment Management LP | 11,219,036 | $7,586,797 | 6.12% |
| Ally Bridge Group (NY) LLC | 3,144,164 | $2,200,915 | 2.58% |
| Altium Capital Management LP | 2,868,000 | $2,007,600 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 5,687,134 | $3,980,994 | 0.72% |
| Soleus Capital Management, L.P. | 8,300,980 | $5,810,686 | 0.54% |
| Octagon Capital Advisors LP | 4,468,114 | $3,127,680 | 0.48% |
| Saturn V Capital Management LP | 1,387,015 | $970,910 | 0.41% |
| Carlyle Group Inc. | 8,761,891 | $6,054,467 | 0.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,040,000 | $2,128,000 | 0.24% |